Patent · US Active

Compositions useful for the treatment of immune-related diseases

US11229670B2 · kind B2 · utility

3Cited by
0References
9Claims
0Family size

Assignee

Inventors

Key dates

Filing dateNov 18, 2017
Grant dateJan 25, 2022
Priority date
Expiry dateMay 19, 2038

Classification

  • Technology area (CPC A)Human Necessities
  • CPC primaryA61Q19/007
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

The present invention relates to a gingival fibroblast-derived product for use in the treatment or prevention of an immune-related disease in an individual.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.